Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...
The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...
Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...
The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...
From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...
Norwich comfortably saw off Stoke 4-2 at Carrow Road to record their first win in four matches and reignite their bid to ...
Norwich City will look to keep their play-off hopes alive when they welcome Stoke City to Carrow Road on Saturday afternoon ...
Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...
After cheering for the contractor who leaked the tax returns of President Trump and other wealthy Americans, the liberal ...
Graham McGarry & Peter Morse react to Crewe's 3-0 home win over Barrow, plus hear from manager Lee Bell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results